Why Is Monopar Therapeutics Stock Surging Over 400% On Thursday? - AstraZeneca ( NASDAQ:AZN ) , ( MNPR )
Monopar Therapeutics Inc. MNPR stock is skyrocketing on Thursday. The company agreed with AstraZeneca Plc's AZN Alexion for an exclusive worldwide license to ALXN-1840 ( bis-choline tetrathiomolybdate ) for Wilson's disease.
| Ticker |
Sentiment |
Impact |
|
AZN
|
Somewhat Bullish
|
30 %
|
|
MNPR
|
Neutral
|
30 %
|
